Breaking News Instant updates and real-time market news.

SBAC

SBA Communications

$244.80 /

+3.86 (+1.60%)

, AMT

American Tower

$230.85 /

+4.41 (+1.95%)

05:19
01/13/20
01/13
05:19
01/13/20
05:19

SBA Communications upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs analyst Brett Feldman upgraded SBA Communications (SBAC) to Buy from Neutral with a price target of $280, up from $214. The analyst expects that "rapidly expanding" 5G coverage, increased availability of 5G devices and site densification around new mid-band spectrum will drive "several years of strong tower leasing activity." Further, from a valuation standpoint, towers look attractive versus other 'high-quality' real estate investment trusts, Feldman tells investors in a research note. Feldman prefers American Tower (AMT) and SBA to Crown Castle (CCI) as he believes the companies offer more exposure to 5G tower demand and more attractive valuations for their core tower businesses. The analyst this morning also upgraded American Tower to Buy and kept a Neutral rating on Crown Castle.

SBAC

SBA Communications

$244.80 /

+3.86 (+1.60%)

AMT

American Tower

$230.85 /

+4.41 (+1.95%)

CCI

Crown Castle

$142.40 /

+2.15 (+1.53%)

  • 27

    Feb

SBAC SBA Communications
$244.80 /

+3.86 (+1.60%)

09/19/19 MSCO
Morgan Stanley downgrades Communications Infrastructure view to In-Line
10/10/19 MSCO
Tower leasing demand looks to be softening, says Morgan Stanley
10/11/19 KEYB
American Tower, SBA Communications should be bought on pullback, says Keybanc
01/10/20 KEYB
American Tower price target raised to $254 from $242 at KeyBanc
AMT American Tower
$230.85 /

+4.41 (+1.95%)

11/01/19 COWN
American Tower price target raised to $260 from $238 at Cowen
01/13/20 GSCO
American Tower upgraded to Buy from Neutral at Goldman Sachs
CCI Crown Castle
$142.40 /

+2.15 (+1.53%)

10/18/19 RHCO
Crown Castle price target raised to $150 from $135 at SunTrust

TODAY'S FREE FLY STORIES

Upgrade
Adidas upgraded to Outperform from Market Perform at Telsey Advisory » 05:22
01/28/20
01/28
05:22
01/28/20
05:22
ADDYY

Adidas

$0.00 /

+ (+0.00%)

Telsey Advisory analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Stratasys should be bought on any weakness from outlook, says Piper Sandler » 05:21
01/28/20
01/28
05:21
01/28/20
05:21
SSYS

Stratasys

$19.62 /

-0.45 (-2.24%)

2019 was a disappointing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Reseller survey shows mixed 3D printing demand in Q4, says Piper Sandler » 05:17
01/28/20
01/28
05:17
01/28/20
05:17
SSYS

Stratasys

$19.62 /

-0.45 (-2.24%)

, DDD

3D Systems

$11.08 /

-0.29 (-2.55%)

Based on feedback from a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Activision Blizzard price target raised to $69 from $62 at Piper Sandler » 05:14
01/28/20
01/28
05:14
01/28/20
05:14
ATVI

Activision Blizzard

$58.32 /

-1.04 (-1.75%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Electronic Arts price target raised to $124 from $106 at Piper Sandler » 05:12
01/28/20
01/28
05:12
01/28/20
05:12
EA

Electronic Arts

$110.62 /

-1.68 (-1.50%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Genpact forms strategic alliance with Amplexor » 05:10
01/28/20
01/28
05:10
01/28/20
05:10
G

Genpact

$43.68 /

-0.66 (-1.49%)

Amplexor and Genpact…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Take-Two price target raised to $141 from $134 at Piper Sandler » 05:10
01/28/20
01/28
05:10
01/28/20
05:10
TTWO

Take-Two

$123.01 /

-2.23 (-1.78%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Regeneron, Sanofi announce FDA Priority Review for Dupixent » 05:08
01/28/20
01/28
05:08
01/28/20
05:08
REGN

Regeneron

$339.50 /

-5.59 (-1.62%)

, SNY

Sanofi

$47.80 /

-0.935 (-1.92%)

Regeneron Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Acceleron price target raised to $135 from $73 at Piper Sandler » 05:08
01/28/20
01/28
05:08
01/28/20
05:08
XLRN

Acceleron

$52.83 /

+0.81 (+1.56%)

Piper Sandler analyst…

Piper Sandler analyst Danielle Brill raised her price target for Acceleron Pharma to $135 from $73 after the Phase 2 proof-of-concept study of sotatercept in pulmonary arterial hypertension met its primary endpoint and key secondary efficacy endpoints. The stock in premarket trading is up 66%, or $35.13, to $88.00. Importantly, the results also met Acceleron's predefined threshold for clinical significance, Brill tells investors in a research note. While few details were provided in the release, the positive findings in this "robust" Phase 2 provides "solid evidence" for sotatercept's role as a disease-modifying agent for pulmonary arterial hypertension, contends the analyst. She reiterates an Overweight rating on Acceleron shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Vivint Smart Home downgraded to In-Line from Outperform at Imperial Capital » 05:05
01/28/20
01/28
05:05
01/28/20
05:05
VVNT

Vivint Smart Home

$11.72 /

-0.01 (-0.09%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
3D Systems downgraded to Neutral from Overweight at Piper Sandler » 05:02
01/28/20
01/28
05:02
01/28/20
05:02
DDD

3D Systems

$11.08 /

-0.29 (-2.55%)

Piper Sandler analyst…

Piper Sandler analyst Troy Jensen downgraded 3D Systems to Neutral from Overweight with an unchanged price target of $12. The shares closed Monday down 30c to $11.08. The analyst sees limited upside from current valuations and limited 2020 catalysts after his Q4 reseller survey indicated "another struggle this quarter" for 3D Systems. However, consensus estimates are "somewhat achievable" as they reflect less than normal seasonality for Q4 and the company appears to be focused on cost cuts to improve profitability, Jensen tells investors in a research note. The analyst, who notes 3D shares have appreciated nearly 30% since the start of the year, says 2020 does not appear to be a big year for new product introductions. He advises investors to wait for pullbacks before getting more constructive on 3D Systems shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
PG&E upgraded to Buy from Neutral at Mizuho » 04:59
01/28/20
01/28
04:59
01/28/20
04:59
PCG

PG&E

$14.07 /

-0.205 (-1.44%)

Mizuho analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Laureate sum-of-the-parts in mid-to-upper $20s per share, says Stifel » 04:56
01/28/20
01/28
04:56
01/28/20
04:56
LAUR

Laureate Education

$17.70 /

+0.04 (+0.23%)

After Laureate Education…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Citigroup communications analyst to hold an analyst/industry conference call » 04:55
01/28/20
01/28
04:55
01/28/20
04:55

Communications Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

Conference/Events
Drug Information Association to hold a conference » 04:55
01/28/20
01/28
04:55
01/28/20
04:55
ABBV

AbbVie

$84.03 /

+0.5 (+0.60%)

, ALLO

Allogene Therapeutics

$22.62 /

-0.81 (-3.46%)

, ALXN

Alexion

$105.38 /

+0.14 (+0.13%)

, BMY

Bristol-Myers

$63.71 /

-0.465 (-0.72%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, CRBP

Corbus Pharmaceuticals

$6.61 /

-0.12 (-1.78%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, EXPO

Exponent

$73.21 /

+0.76 (+1.05%)

, GSK

GlaxoSmithKline

$46.48 /

-0.755 (-1.60%)

, HALO

Halozyme

$19.17 /

+0.1 (+0.52%)

, IQV

Iqvia

$157.15 /

-0.985 (-0.62%)

, LLY

Eli Lilly

$138.38 /

-0.71 (-0.51%)

, PFE

Pfizer

$40.16 /

+0.34 (+0.85%)

Pharmacovigilance &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
JPMorgan agribusiness analysts to hold an analyst/industry conference call » 04:55
01/28/20
01/28
04:55
01/28/20
04:55

Food &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Flexion management to meet with Craig-Hallum » 04:55
01/28/20
01/28
04:55
01/28/20
04:55
FLXN

Flexion

$17.60 /

+0.03 (+0.17%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Herman Miller management to meet with Sidoti » 04:55
01/28/20
01/28
04:55
01/28/20
04:55
MLHR

Herman Miller

$40.58 /

-0.32 (-0.78%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Durable Goods Orders to be reported at 08:30 » 04:55
01/28/20
01/28
04:55
01/28/20
04:55

December Durable Goods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
8-Week Bill Announcement to be released at 11:00  04:55
01/28/20
01/28
04:55
01/28/20
04:55
 
General news
8-Week Bill Announcement to be released at 11:00  04:55
01/28/20
01/28
04:55
01/28/20
04:55
 
Conference/Events
Stephens healthcare analysts to hold an analyst/industry conference call » 04:55
01/28/20
01/28
04:55
01/28/20
04:55

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Paycom to replace WellCare in S&P 500 at open on 1/28 » 04:55
01/28/20
01/28
04:55
01/28/20
04:55
PAYC

Paycom

$312.52 /

-2.06 (-0.65%)

, WCG

WellCare

$350.01 /

+ (+0.00%)

, CNC

Centene

$63.42 /

-3.16 (-4.75%)

Centene (CNC) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Foundation Building Materials management to meet with SunTrust » 04:55
01/28/20
01/28
04:55
01/28/20
04:55
FBM

Foundation Building Materials

$18.46 /

-0.28 (-1.49%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Workhorse Group management to meet with Oppenheimer » 04:55
01/28/20
01/28
04:55
01/28/20
04:55
WKHS

Workhorse Group

$3.08 /

+ (+0.00%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.